BACKGROUND AND PURPOSE: BOLD MR imaging combined with a technique for precision control of end-tidal pCO 2 was used to produce quantitative maps of CVR in patients with Moyamoya disease. The technique was validated against measures of disease severity by using conventional angiography; it then was used to study the relationship between CVR, vascular steal, and disease severity.
M
oyamoya disease is a vasculopathy affecting the proximal circle of Willis vessels characterized by progressive narrowing and formation of secondary collaterals. Blood flow distal to these stenotic vessels is thought to be maintained by a drop in vascular resistance mediated by small artery and arteriolar vasodilation. As the disease progresses, however, the ability of this autoregulatory system or CVR to preserve adequate perfusion is lost when compensatory arteriolar dilation reaches a maximum. Further increases in vascular resistance at the stenosis ultimately lead to tissue oligemia and possible ischemia. Measurements of CVR can provide valuable information for planning surgical revascularization, assessing the success of such a procedure postoperatively, and predicting the recurrence of focal neurologic symptoms. 1 CO 2 is a potent vasodilator of the cerebrovasculature and can be used to test the responsiveness of the autoregulatory system in patients with Moyamoya disease. Measurements of regional CBF in response to changes in end-tidal pCO 2 have been accomplished with a number of imaging modalities, including PET, 2 SPECT, 3 CT perfusion, 4 and MR imaging. BOLD MR imaging measurement of CVR, in particular, has recently been shown to be highly correlated with CBF in patients with steno-occlusive disease caused by atherosclerosis or Moyamoya disease. 5 Blood flow manipulation is typically achieved by acetazolamide stress, breath-hold techniques, or steady-state CO 2 administration via a face mask. These methods produce inconsistent changes in blood flow. Recently, we have implemented a method for precision control of end-tidal pCO 2 and pO 2 , 6 permitting accurate correlation of changes in pCO 2 with the BOLD MR imaging signal-intensity response.
In the present work, we used BOLD MR imaging in combination with precise iso-oxic changes in end-tidal CO 2 to produce quantitative maps of CVR in patients with Moyamoya disease. To validate this technique, we correlated measurements of CVR with a modified Suzuki score, which is a measure of disease severity determined by using conventional angiography. The measures of CVR were also correlated with the extent of steal within a vascular territory, providing insight into the physiology of autoregulatory reserve.
Materials and Methods

Patient Selection and Angiographic Scoring
A retrospective analysis was performed on patients with Moyamoya disease undergoing cerebrovascular reactivity measurements before surgical revascularization at our institution. Ethics approval was obtained through our research institute's ethics committee and written consent was given by all participants. Patients without structural brain disease such as ischemic or hemorrhagic stroke and those with a prior conventional angiogram with 6-vessel injection obtained within 6 months before the CVR study were included in the study. A total of 11 patients who underwent a CVR study between October 2005 and June 2007 were evaluated.
The degree of Moyamoya disease as visualized on conventional angiography was scored by a neuroradiologist (D.J.M.) using a modified Suzuki score 7 
Cerebrovascular Reactivity by BOLD MR imaging
MR imaging was performed on a 3T Signa HD clinical MR imaging scanner (GE Medical Systems, Milwaukee, Wisconsin) equipped with 40 mT/m gradient coils and a standard head coil. A standard singleshot BOLD protocol with a spiral readout (TE, 40 ms) was used. The imaging time was 12 minutes for a total acquisition of 320 volumes. Each volume contained 28 sections with a resolution of 3.75 ϫ 3.75 ϫ 4.5 mm. High resolution T1-weighted images were obtained to provide anatomic coregistration. Patients breathed via a tight-fitting mask that was attached to a circuit consisting of a 3 valve manifold and reservoirs for externally supplied gas and exhaled gas. The valves are configured such that external gas is inhaled first and, if the breath size exceeds the gas flow entering the circuit, the balance of inhaled gas is made up with the previously exhaled gas (i.e., rebreathing). External gas is supplied by a custom built computer-controlled gas blender (Respiract; Thornhill Research, Toronto, Canada). It supplies O 2 , and mixtures of CO 2 and N 2 (nitrogen) with O 2 , to achieve target endtidal CO 2 and end-tidal O 2 independent of breathing pattern. 8 This resulted in near square wave transitions (within 1-3 breaths) and precise, sustained end-tidal gas levels. We used this approach to cycle end-tidal CO 2 between 40 and 50 mmHg in 90 sec cycles while keeping end tidal O 2 at 100 mmHg during BOLD signal acquisition.
Data Analysis
Image analysis was performed by using AFNI, an open-source environment used for processing and displaying functional MR imaging data. BOLD MR imaging data were transformed onto the Talairach coordinate system, and the BOLD data were temporally shifted and correlated with the patient's CO 2 waveform. A least-squares regression analysis of the BOLD signal intensity versus the CO 2 waveform for each voxel was calculated. For each vascular territory (ACA, MCA, PCA), the CVR for positively and negatively reacting voxels was determined. CVR for each voxel was calculated according to the following:
where ⌬S is the change in MR signal intensity for a given voxel that occurs between peak and trough CO 2 levels and ⌬pCO 2 is the change in end-tidal CO 2 in mmHg. In healthy brain, CVR is positive, reflect- 0  III  0  0  0  2  0  0  2  36  M  Headache  0  III  0  0  0  2  0  0  3  45  M  TIA (left weakness)  II  IV  2  2  0  2  0  0  4  39  F  TIA (right weakness)  II  0  0  0  2  0  0  0  5  33  F  Headache  II  II  2  1  1  1  0  0  6  35  F  TIA (left weakness)  IV  IV  2  2  1  1  1  1  7 ing an increase in CBF in response to increasing pCO 2 . In areas of brain in which blood flow is reduced in response to increasing pCO 2 , CVR is negative. Areas of negative CVR are generally thought to be the result of the vascular "steal" phenomenon, whereby hypercapnea leads to diversion of blood from areas of brain where arterioles are maximally vasodilated and vascular resistance is already minimized to areas of the brain capable of decreasing vascular resistance in response to a CO 2 stimulus. 5 The mean of all positively reacting voxels in a vascular territory (Mean CVR pos ) and the mean of all negatively reacting voxels in a vascular territory (Mean CVR neg ) were calculated. The Mean CVR combined for a given vascular territory was calculated as a weighted average of negative-and positive-reacting voxels as follows:
Mean CVR combined ϭ f neg ϫ Mean CVR neg ϩ f pos ϫ Mean CVR pos ,
where f neg and f pos are the fraction of negatively and positively reacting voxels respectively. 
Statistical Analysis
Statistical analysis was performed by using Prism (GraphPad Software, La Jolla, California). The correlation between Mean CVR combined for the MCA and ACA territories and the modified Suzuki score, and the correlation between Mean CVR combined for combined ACA and MCA territories and presence of Moyamoya and pial collaterals were calculated with a Pearson correlation coefficient. One-way ANOVA was performed to compare the Mean CVR combined for vascular territories with different Suzuki scores. An unpaired t test was used to compare the Mean CVR combined for vascular territories with and without Moyamoya or pial collaterals.
Results
The study group comprised 7 females and 4 males with an age range between 10 and 48 years. Five patients had unilateral disease and 6 patients had bilateral disease. A total of 66 vascular territories were analyzed (11 each of the right and left ACA, right and left MCA, and right and left PCA). CVR maps are shown for 2 patients with varying degrees of Moyamoya disease and the corresponding conventional angiograms for the affected vascular territories (Figs 1 and 2) . The CVR maps qualitatively show a correlation between regional changes in CVR and angiographic features of Moyamoya disease. The Mean CVR combined for MCA and ACA territories was plotted against the degree of Moyamoya disease as observed on conventional angiography and measured by the modified Suzuki score (Fig 3) . There was good correlation between Mean CVR combined and Suzuki class for MCA and ACA territories (Pearson correlation coefficient, Ϫ0.7560 and Ϫ0.6140, respectively); however, the correlation was better for the MCA territory. Vascular territories with Suzuki score Ͼ0 had a statistically significant lower CVR score compared with diseasefree areas (1-way ANOVA, P Ͻ .0001 for MCA and ACA territories). There was a decreasing trend of Mean CVR combined with increasing disease score, but the difference was not statistically significant.
The Mean CVR combined was calculated for combined ACA and MCA territories with Moyamoya and pial collaterals (MϩPϩ), Moyamoya collaterals alone (MϩPϪ), and no collaterals (MϪPϪ) (Fig 4) . There was a good correlation between Mean CVR combined and the presence of collateral vessels (Pearson correlation coefficient, Ϫ0.7466). Territories with vessel collaterals had significantly lower Mean CVR combined (Mean CVR combined Ϯ SE ϭ 0.068 Ϯ 0.031 and 0.021 Ϯ 0.013 for MϩPϪ and MϩPϩ, respectively) compared with territories with no collaterals (Mean CVR combined Ϯ SE ϭ 0.20 Ϯ 0.017). Territories containing Moyamoya and pial collaterals (MϩPϩ) had a lower Mean CVR combined compared with territories with Moyamoya vessels alone (MϩPϪ), but this difference was not statistically significant (P ϭ .11, unpaired t test).
To examine the dependence of CVR on the extent of vascular steal, we generated plots of Mean CVR pos , Mean CVR neg , and Mean CVR combined versus the fraction of negatively reacting voxels (f neg ) for all ACA, MCA, and PCA territories. Vascular territories affected by Moyamoya disease (Suzuki Ͼ0) have more vascular steal (higher f neg ) compared with diseasefree territories (Suzuki ϭ 0). A nonlinear decrease in Mean CVR pos with f neg was found (Fig 5A) . An exponential decay with a plateau of 0 was fitted to the data (R 2 ϭ 0.45). A similar trend for Mean CVR combined against f neg (Fig 5B) was fitted to an exponential decay with a plateau of Ϫ0.09 (R 2 ϭ 0.72). Extrapolating from this fit, the x-intercept (Mean CVR combined ϭ 0) occurs with f neg ϭ 0.52. A plot for Mean CVR neg illustrates the independence of Mean CVR neg over a wide range of f neg values (Fig 5C) .
Discussion
Measurement of CVR with BOLD MR imaging and the CO 2 rebreathing circuit used in the current study has a number of advantages over existing methods. Nuclear medicine techniques such as PET and SPECT have poor spatial and temporal resolution and involve the administration of radioactive tracers. Changes in CBF measured with CT perfusion have been shown to correlate well with angiographic scoring of Moyamoya disease. 4 The accurate quantification of CBF by using CT perfusion is dependent on an AIF, which is difficult to define in circulation affected by Moyamoya disease. In addition, studies that rely on breath-hold or acetazolamide stress cannot reproducibly create changes in end-tidal pCO 2 and, therefore, cannot accurately quantify CVR. BOLD MR imaging is a readily accessible technique that can produce quantitative maps of CVR with high temporal and spatial resolution, requires no radioactive tracer, and is not dependent on an AIF. Furthermore, the rebreathing technique used in the current study produces reproducible changes in end-tidal pCO 2 , allowing truly quantitative and accurate mapping of CVR.
Using the BOLD MR imaging technique with the rebreathing circuit, we found a good correlation between Mean CVR combined and the Suzuki score. The Mean CVR combined decreases with increasing Suzuki score; however, the difference was not statistically significant between vascular territories for a Suzuki score of Ͼ0. This is not completely unexpected because angiographic scoring of upstream feeding vessels may not adequately reflect the perfusion in downstream tissue. Furthermore, we have shown that the effect on Mean CVR combined is diminished as disease burden increases (Fig  5B) , so while a significant difference between Mean CVR combined for a vascular territory with a Suzuki score of 0 and a Suzuki score of Ͼ0 may be significant, we expect a smaller difference between vascular territories with non-zero Suzuki scores.
The correlation between CVR and the presence of Moyamoya and pial collaterals suggests that the presence of these vessels is associated with poor vascular reactivity that is not adequately compensated by collateralization. Vascular territories with pial and Moyamoya vessels had a nonsignificant but lower Mean CVR combined compared with vascular territories with Moyamoya vessels alone. The presence of pial collaterals may, therefore, represent a more severe disease burden as measured by Mean CVR combined ; however, further measurements will be needed to clarify this relationship.
Measurements indicate that a nonlinear relationship exists between Mean CVR pos and f neg (Fig 5A) . For small values of f neg , there is an initial large decrease in Mean CVR pos for small changes in f neg . As f neg increases, the effect on Mean CVR pos is diminished. In contrast, the mean reactivity of negatively reacting voxels (Mean CVR neg ) is relatively constant over a range of f neg . The Mean CVR combined is, therefore, predominantly affected by changes in Mean CVR pos for small values of f neg . As the amount of steal increases in a given vascular territory, the decrease in Mean CVR combined is mainly determined by the increasing extent of steal (f neg ) and not significantly by decreasing Mean CVR pos or Mean CVR neg . No attempt has been made to mathematically model the relationship between CVR and f neg , but the results presented here demonstrate a reproducible relationship between these parameters in all vascular territories studied and in multiple patients.
There was a decreasing trend between Mean CVR combined and increasing Suzuki score and vessel collateralization, but the difference was not statistically significant. Statistically significant differences may exist; however, the study was limited because of the small number of patients analyzed. Other limitations of this study were the deficiency of patients with mild Moyamoya disease (Suzuki ϭ I) and the retrospective nature of the study.
Conclusions
BOLD MR imaging in combination with precision control of end-tidal pCO 2 and pO 2 is an easily implemented technique that can produce reproducible and quantitative maps of CVR. In the present work, we have demonstrated how this technique correlates well with existing measures of Moyamoya disease burden by using conventional angiography and, therefore, validates the use of BOLD MR imaging for this purpose. However BOLD MR imaging takes this correlation one step further by providing truly quantitative maps of the spatial severity of Moyamoya disease.
